Skip Navigation
Search Menu
Find a Doctor


Photo of Dr. Joel Nee-Lartey Blankson, M.D., Ph.D.

Joel Nee-Lartey Blankson, M.D., Ph.D.

Associate Professor of Medicine


Appointment Phone


Main Location

Johns Hopkins Medicine - Green Spring Station

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Associate Professor of Medicine
  • Associate Professor of Molecular and Comparative Pathobiology



Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-1725

10755 Falls Road
Pavilion I
Lutherville, MD 21093 map

Johns Hopkins Outpatient Center

Appointment Phone: 410-955-1725

601 N. Caroline Street
Baltimore, MD 21287 map

The Johns Hopkins Hospital

Appointment Phone: 410-955-1725

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map

Contact for Research Inquiries

833 Miller Research Building
, map


HIV Pathogenesis, Infectious Disease

Research Interests

Natural Control of HIV-1 Infection

    Additional Information

  • Education +


    • Cornell University Medical College / MD; Medicine (1995)


    • Johns Hopkins University School of Medicine / Infectious Diseases (1998)


    • Johns Hopkins University School of Medicine / Infectious Diseases (2002)


    • American Board of Internal Medicine / Infectious Disease (2002, 2012)
  • Research & Publications +

    Selected Publications

    1: Salgado M, Swanson MD, Pohlmeyer CW, Buckheit RW 3rd, Wu J, Archin NM,Williams TM, Margolis DM, Siliciano RF, Garcia JV, Blankson JN. HLA-B*57 EliteSuppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and CauseCD4+ T cell Depletion in Humanized BLT Mice. J Virol. 2014 Jan 3. [Epub ahead of print] PubMed PMID: 24390323.2: Pohlmeyer CW, Buckheit RW 3rd, Siliciano RF, Blankson JN. CD8+ T cells fromHLA-B*57 elite suppressors effectively suppress replication of HIV-1 escapemutants. Retrovirology. 2013 Dec 12;10:152. doi: 10.1186/1742-4690-10-152. PubMedPMID: 24330837; PubMed Central PMCID: PMC3878989.3: Chiu YL, Shan L, Huang H, Haupt C, Bessell C, Canaday DH, Zhang H, Ho YC,Powell JD, Oelke M, Margolick JB, Blankson JN, Griffin DE, Schneck JP. Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest. 2013 Dec 2. pii: 70510. doi: 10.1172/JCI70510. [Epub ahead of print] PubMed PMID: 24292711; PubMedCentral PMCID: PMC3871241.4: Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI, Lai J, BlanksonJN, Siliciano JD, Siliciano RF. Replication-competent noninduced proviruses inthe latent reservoir increase barrier to HIV-1 cure. Cell. 2013 Oct24;155(3):540-51. doi: 10.1016/j.cell.2013.09.020. Epub 2013 Oct 24. PubMed PMID:24243014; PubMed Central PMCID: PMC3896327.5: Salgado M, Gandhi S, Buckheit RW, Berkenblit GV, Blankson JN. Evolution of an Attenuated HIV-1 Isolate in an Elite Suppressor. AIDS Res Hum Retroviruses. 2013 Nov 13. [Epub ahead of print] PubMed PMID: 24117037.6: Buckheit RW 3rd, Siliciano RF, Blankson JN. Primary CD8+ T cells from elitesuppressors effectively eliminate non-productively HIV-1 infected resting andactivated CD4+ T cells. Retrovirology. 2013 Jul 1;10:68. doi:10.1186/1742-4690-10-68. PubMed PMID: 23816179; PubMed Central PMCID: PMC3702406.7: Laird GM, Eisele EE, Rabi SA, Lai J, Chioma S, Blankson JN, Siliciano JD,Siliciano RF. Rapid quantification of the latent reservoir for HIV-1 using aviral outgrowth assay. PLoS Pathog. 2013;9(5):e1003398. doi:10.1371/journal.ppat.1003398. Epub 2013 May 30. PubMed PMID: 23737751; PubMedCentral PMCID: PMC3667757.8: Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC,Brookmeyer R, Quinn TC, Laeyendecker O. Effect of natural and ARV-induced viralsuppression and viral breakthrough on anti-HIV antibody proportion and avidity inpatients with HIV-1 subtype B infection. PLoS One. 2013;8(2):e55525. doi:10.1371/journal.pone.0055525. Epub 2013 Feb 20. PubMed PMID: 23437058; PubMedCentral PMCID: PMC3577851.9: Buckheit RW 3rd, Salgado M, Silciano RF, Blankson JN. Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors. J Virol. 2012Dec;86(24):13679-88. doi: 10.1128/JVI.02439-12. Epub 2012 Oct 10. PubMed PMID:23055552; PubMed Central PMCID: PMC3503034.10: Durand CM, Blankson JN, Siliciano RF. Developing strategies for HIV-1eradication. Trends Immunol. 2012 Nov;33(11):554-62. doi:10.1016/ Epub 2012 Aug 3. Review. PubMed PMID: 22867874.11: Buckheit RW 3rd, Salgado M, Martins KO, Blankson JN. The implications ofviral reservoirs on the elite control of HIV-1 infection. Cell Mol Life Sci. 2013Mar;70(6):1009-19. doi: 10.1007/s00018-012-1101-7. Epub 2012 Aug 4. Review.PubMed PMID: 22864624.12: Thayil SM, Ho YC, Bollinger RC, Blankson JN, Siliciano RF, Karakousis PC,Page KR. Mycobacterium tuberculosis complex enhances susceptibility of CD4 Tcells to HIV through a TLR2-mediated pathway. PLoS One. 2012;7(7):e41093. doi:10.1371/journal.pone.0041093. Epub 2012 Jul 23. PubMed PMID: 22844428; PubMedCentral PMCID: PMC3402510.13: Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, MargolickJB, Blankson JN, Siliciano RF. Stimulation of HIV-1-specific cytolytic Tlymphocytes facilitates elimination of latent viral reservoir after virusreactivation. Immunity. 2012 Mar 23;36(3):491-501. doi:10.1016/j.immuni.2012.01.014. Epub 2012 Mar 8. PubMed PMID: 22406268; PubMedCentral PMCID: PMC3501645.14: Buckheit RW 3rd, Allen TG, Alme A, Salgado M, O'Connell KA, Huculak S,Falade-Nwulia O, Williams TM, Gallant JE, Siliciano RF, Blankson JN. Host factorsdictate control of viral replication in two HIV-1 controller/chronic progressortransmission pairs. Nat Commun. 2012 Mar 6;3:716. doi: 10.1038/ncomms1697. PubMedPMID: 22395607; PubMed Central PMCID: PMC3549550.15: Durand C, Ambinder R, Blankson J, Forman S. HIV-1 and hematopoietic stem celltransplantation. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S172-6. doi: 10.1016/j.bbmt.2011.10.027. Review. PubMed PMID: 22226103; PubMed Central PMCID: PMC3615639.16: Witwer KW, Watson AK, Blankson JN, Clements JE. Relationships of PBMCmicroRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infectedelite suppressors and viremic patients. Retrovirology. 2012 Jan 12;9:5. doi:10.1186/1742-4690-9-5. PubMed PMID: 22240256; PubMed Central PMCID: PMC3292811.17: Salgado M, Rabi SA, O'Connell KA, Buckheit RW 3rd, Bailey JR, Chaudhry AA,Breaud AR, Marzinke MA, Clarke W, Margolick JB, Siliciano RF, Blankson JN.Prolonged control of replication-competent dual- tropic human immunodeficiencyvirus-1 following cessation of highly active antiretroviral therapy.Retrovirology. 2011 Dec 5;8:97. doi: 10.1186/1742-4690-8-97. PubMed PMID:22141397; PubMed Central PMCID: PMC3293762.18: O'Connell KA, Rabi SA, Siliciano RF, Blankson JN. CD4+ T cells from elitesuppressors are more susceptible to HIV-1 but produce fewer virions than cellsfrom chronic progressors. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E689-98. doi: 10.1073/pnas.1108866108. Epub 2011 Aug 22. PubMed PMID: 21873218; PubMedCentral PMCID: PMC3174588.19: Blankson JN. Killing the messenger to maintain control of HIV. Nat Med. 2011 Aug 4;17(8):927-8. doi: 10.1038/nm.2427. PubMed PMID: 21818087.20: O'Connell KA, Hegarty RW, Siliciano RF, Blankson JN. Viral suppression ofmultiple escape mutants by de novo CD8(+) T cell responses in a humanimmunodeficiency virus-1 infected elite suppressor. Retrovirology. 2011 Aug3;8:63. doi: 10.1186/1742-4690-8-63. PubMed PMID: 21812985; PubMed Central PMCID:PMC3173334.
  • Academic Affiliations & Courses +

    Graduate Program Affiliation


    Cellular and Molecular Medicine

  • Activities & Honors +
  • Videos & Media +
Is This You? Edit Profile